Ultimovacs

Developer of next-generation cell therapies for solid tumors

placeOslo, Oslo, Norway calendar_todayFounded 2011 groups25 employees language ultimovacs.com

Registered entities

Innovation

4 patent families — focus: Human necessities; filing pace steady. Cited 182 times.

YearFilings
20201
20211
20222
20232
20243
20251

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital267%
Private equity133%
Coming soon